iVascular, S.L.U.
Corporate brand
UnclaimediVascular is a Barcelona-based company founded in 2010 that develops advanced medical devices and therapies for disorders of the vascular system.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
iVascular is a fast-growing company founded in 2010 in Barcelona (Spain) with the aim of developing medical devices and therapies for the treatment of disorders of the vascular system. It describes itself as an international project founded by 5 industrial companies, and states it has fulfilled the quality standards of more than 70 countries. Its therapeutic areas include coronary, peripheral and neurointerventionism catheters.
History
iVascular is a fast-growing company founded in 2010 in Barcelona (Spain) with the aim of developing medical devices and therapies for the treatment of disorders of the vascular system. The team that started iVascular owns more than 30 years of experience in the field of vascular devices. iVascular describes itself as an international project founded by 5 industrial companies, and states it has been able to fulfill the quality standards of more than 70 countries.
Products and positioning
To become a reference in the vascular field by empowering the value of technology and innovation.
Coronary catheters
Catheters for the treatment of endovascular stenotic, restenotic or occlusive lesions located in the coronary arteries, to improve myocardial perfusion.
Peripheral catheters
Catheters for the treatment of endovascular injuries located below the iliac arch including iliac, femoral, popliteal and infrapopliteal arteries, the renal artery and the biliary tract, as well as arteriovenous fistulas.
Neurointerventionism catheters
Catheters for the treatment of ischemic stroke by restoring blood flow.
Luminor DCB
A drug-coated balloon product; a press release notes it is now in Japan.
Angiolite Drug-Eluting Stent
A drug-eluting stent; a press release reports exceptional long-term outcomes in real-life clinical practice.
Amber
A new embolic liquid; iVascular initiated the OPAL study with it.
Recent events
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/ivascular-slu-spain · Editorial policy · How profiles are compiled